| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lale White is Director at CRDF. Lale White's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $98K at current prices.
Net of sales, the CRDF filings show accumulation of 84,930 shares.
Lale White has 11 Form 4 filings on record from April 2020 to June 2026, all as Director at Cardiff Oncology (CRDF), 2020–2026.
The 11 reported transactions were 8 option or other derivative awards, 2 open-market purchases and 1 option exercise.
Counted by filing, the open-market trades come to 2 purchases worth about $125K and no sales.
The largest open-market purchase was 69,930 shares of CRDF at an average $1.43 on May 14, 2020, about $100K.